RE: RE : Coronavirus Collaboration ect11 Jul 2020 14:18
Vaccines normally take years to develop unless ...
When asked how they managed to move the usually lengthy process of vaccine approval along so quickly, Professor Sarah Gilbert, who is leading the study, said it was their ongoing research into Disease X – an as yet unknown infectious agent earmarked as a potential pandemic in the making – which allowed them to pivot so quickly to Covid-19.
“Last year my team was already working on vaccines against Lassa Fever, Mers, which is another coronavirus vaccine, and also Disease X,” Professor Gilbert said.
“Obviously we didn’t know what kind of pathogen Disease X was going to be but we were putting plans in place in case it did pop up and we needed to respond to it.”
The particular type of technology the team is testing has also quickened the process.
“The ChAdOx vaccine, is a so-called platform technology, which can be used to make vaccines against lots of different diseases.”